Φορτώνει......
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Brain Behav |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/ https://ncbi.nlm.nih.gov/pubmed/28948074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|